{{Rsnum
|rsid=7769153
|Gene=EPB41L2
|Chromosome=6
|position=130935224
|Orientation=plus
|GMAF=0.0932
|Gene_s=EPB41L2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.0 | 6.2 | 93.8
| HCB | 2.9 | 21.2 | 75.9
| JPT | 0.9 | 26.5 | 72.6
| YRI | 2.7 | 30.6 | 66.7
| ASW | 1.8 | 22.8 | 75.4
| CHB | 2.9 | 21.2 | 75.9
| CHD | 0.0 | 18.3 | 81.7
| GIH | 0.0 | 16.8 | 83.2
| LWK | 2.7 | 27.3 | 70.0
| MEX | 0.0 | 12.1 | 87.9
| MKK | 0.0 | 11.5 | 88.5
| TSI | 0.0 | 8.8 | 91.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22331829
|Trait=None
|Title=Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.
|RiskAllele=
|Pval=2E-7
|OR=10.3000
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}